NeoGenomics (NEO) Tops Q2 EPS by 1c

NeoGenomics (NASDAQ: NEO) reported Q2 EPS of $0.05, $0.01 better than the analyst estimate of $0.04. Revenue for the quarter came in at $67.7 million versus the consensus estimate of $66.18 million.

For earnings history and earnings-related data on NeoGenomics (NEO) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• Jefferies Starts DBS Group Holdings (DBS:SP) (DBSDY) at Buy
• BofA Securities Starts PhysicsWallah Ltd (PWL:IN) at Underperform